Ostarine, also known as MK-2866 is a SARM (selective androgen receptor module) created by GTx to avoid and treat muscle wasting. It can later on be a cure for avoiding atrophy (total wasting away of a body part), cachexia, sarcopenia and Hormone or Test Replacement Therapy.
This type of SARM cannot only retain lean body mass but as well as increase it. Ostarine is often mistaken as S1 but S1 was created earlier and is no longer going through more expansion.
An experimental drug meant to control lipids and increase the level of HDL, or good cholesterol, in the
A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARd agonist. Exhibits selectivity for PPARd
compared to PPARα and PPARγ. Does not exibit any activity against other nuclear or non-nuclear receptors.
Reported to increase cholesterol efflux and ABAC1 expression in macrophages, fibroblasts, and intestinal cells.
Shines best when used for gaining lean muscle (bulking) as it is the most anabolic of all the SARMS. Suggested dosage is 25 mg for 4-6 weeks. PCT is not necessary. An increase of 6 lbs. of lean, keepable gains can be observed during this period.
Ostarine shines in recomping due to its nutrient portioning results. Calorie is used to build muscle which helps in weight loss and enhancing muscle mass and strength. Suggested dosing is 12.5-25 mg for 4-8 weeks.
COA of MK-2866:
|Appearance||An odorless, almost white or white powder||pass|
|Identificaton||The retention time of the major peak is|
confirm to the RS
|Loss on Drying||Not more than 0.5%||0.33%|
|Assay(HPLC)||Not less than 99.0%||99.59%|
|Ignition residue||Not more than 0.1%||pass|
|Heavy metal||Not more than 20 ppm||pass|